1. Home
  2. TRST vs VOR Comparison

TRST vs VOR Comparison

Compare TRST & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TrustCo Bank Corp NY

TRST

TrustCo Bank Corp NY

N/A

Current Price

$47.57

Market Cap

834.0M

Sector

Finance

ML Signal

N/A

Logo Vor Biopharma Inc.

VOR

Vor Biopharma Inc.

N/A

Current Price

$14.71

Market Cap

702.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TRST
VOR
Founded
1902
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
834.0M
702.4M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
TRST
VOR
Price
$47.57
$14.71
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$45.33
AVG Volume (30 Days)
67.9K
1.0M
Earning Date
04-21-2026
05-11-2026
Dividend Yield
3.25%
N/A
EPS Growth
26.46
N/A
EPS
3.25
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$14.58
N/A
Revenue Growth
N/A
N/A
52 Week Low
$30.17
$0.13
52 Week High
$48.45
$49.95

Technical Indicators

Market Signals
Indicator
TRST
VOR
Relative Strength Index (RSI) 64.22 49.33
Support Level $44.46 $11.74
Resistance Level N/A $14.73
Average True Range (ATR) 1.27 0.96
MACD 0.14 -0.10
Stochastic Oscillator 100.00 33.13

Price Performance

Historical Comparison
TRST
VOR

About TRST TrustCo Bank Corp NY

Trustco Bank Corp N Y is a savings and loan holding company. The core part of a business consists of accepting deposits and making loans and investments. It offers a range of both personal and business banking services. The company's product includes savings accounts; retirement accounts; money market account; mortgages; building loans; auto loans and others. The company derives revenue from the business of Banking. TrustCo lends in the geographic territory of its branch locations in New York, Florida, Massachusetts, New Jersey, and Vermont.

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

Share on Social Networks: